Leonteq Securities’s Spyre Therapeutics SYRE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$8.99K Buy
+101
New +$9.7K ﹤0.01% 1023

Other funds holding SYRE

Leonteq Securities's SYRE Position: Q3 2026 in Review

Leonteq Securities opened a new position in Spyre Therapeutics (SYRE) in Q3 2026: 101 shares worth $8.99K. The stake represents ﹤0.01% of the portfolio and ranks #1023 among its holdings.

197 funds tracked by Wall St. Rank hold SYRE as of Q3 2026.

  • Leonteq Securities held 101 shares of Spyre Therapeutics worth $8.99K as of Q3 2026.
  • Spyre Therapeutics was a new Leonteq Securities position in Q3 2026.
  • Spyre Therapeutics made up ﹤0.01% of Leonteq Securities's portfolio in Q3 2026, its #1023 holding.
  • 197 funds tracked by Wall St. Rank held Spyre Therapeutics as of Q3 2026.

Based on Leonteq Securities's 13F filing for Q3 2026, filed 29 Oct 2026.